Histidine

Histidine

SCHEMBL4778276

CC(C)C[C@H](N)C(=O)OC(=O)[C@@H](N)CCCCN.N=C(N)NCCC[C@H](N)C(=O)Oc1ccc(C[C@H](N)C(=O)O)cc1.N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
NPY4R P50391 11/20 0.40
NPY1R P25929 6/20 0.40
NPY2R P49146 4/20 0.39
NPY5R Q15761 4/20 0.39
ITGB3 P05106 1/20 0.38
ITGA2B P08514 1/20 0.38
THRB P10828 1/20 0.34
MC4R P32245 1/20 0.34
SLC7A5 Q01650 1/20 0.34
OPRM1 P35372 3/20 0.34
OPRK1 P41145 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL8318272 0.90 ITGB3 (0.43) NPY4RNPY1RNPY2RNPY5RITGB3
SCHEMBL10613823 0.90 NPY4R (0.47) NPY4RNPY1RNPY2RNPY5RITGB3
Histidine SCHEMBL2330373 0.89 SLC7A5 (0.41) NPY4RNPY1RNPY2RNPY5RITGB3
Histidine SCHEMBL2331922 0.88 NPY4R (0.37) NPY4RNPY1RNPY2RNPY5RITGB3
Arginine SCHEMBL8587378 0.87 APLNR (0.37) NPY4RNPY1RNPY2RNPY5RMC4R
Arginine SCHEMBL8744510 0.87 NPY4R (0.44) NPY4RNPY1RNPY2RNPY5RITGB3
Arginine SCHEMBL8315939 0.86 SLC7A5 (0.40) NPY4RNPY1RNPY2RNPY5RITGB3
Arginine SCHEMBL8317787 0.86 SLC7A5 (0.40) NPY4RNPY1RNPY2RNPY5RITGB3
SCHEMBL17363643 0.86 FNTA (0.39) NPY4RNPY1RNPY2RNPY5RITGB3
Arginine SCHEMBL29052768 0.85 NPY4R (0.39) NPY4RNPY1RNPY2RNPY5RTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1076097-B1 METHOD FOR CONTROLLING CLEAVAGE BY OmpT PROTEASE ASUBIO PHARMA CO LTD (JP) 2008-11-12 EP disclosed
US-7344856-B1 Method of controlling cleavage by OmpT protease ASUBIO PHARMA CO. LTD. (JP) 2008-03-18 US disclosed
EP-1076097-A1 METHOD FOR CONTROLLING CLEAVAGE BY OmpT PROTEASE SUNTORY LIMITED (JP) 2001-02-14 EP disclosed